NovaBay Pharmaceuticals, Inc.
NBY
$0.6001
$0.00010.02%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.21M | -1.21M | -1.59M | -3.21M | -4.11M |
| Total Depreciation and Amortization | 95.00K | 95.00K | 179.00K | 12.00K | 95.00K |
| Total Amortization of Deferred Charges | 3.00K | 145.00K | 311.00K | 415.00K | 571.00K |
| Total Other Non-Cash Items | -87.00K | 22.00K | 287.00K | 952.00K | 2.34M |
| Change in Net Operating Assets | 229.00K | -1.11M | 230.00K | 57.00K | 290.00K |
| Cash from Operations | -972.00K | -2.06M | -578.00K | -1.78M | -816.00K |
| Capital Expenditure | 0.00 | -2.00K | -2.00K | -2.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 0.00 | 1.07M | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -2.00K | -2.00K | 1.07M | -3.00K |
| Total Debt Issued | 500.00K | -- | -- | -- | 0.00 |
| Total Debt Repaid | 0.00 | -790.00K | -622.00K | -578.00K | -704.00K |
| Issuance of Common Stock | 0.00 | 2.88M | 226.00K | -- | 565.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -96.00K | -19.00K | 113.00K |
| Cash from Financing | 500.00K | 2.09M | -492.00K | -597.00K | -26.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 126.00K | -- | -- | -- | 590.00K |
| Net Change in Cash | -346.00K | 26.00K | -1.07M | -1.31M | -255.00K |